Crimean-Congo hemorrhagic fever virus vaccine: past, present, and future

被引：4
作者：
Behboudi, Emad [1 ]
Kakavandi, Ehsan [2 ,3 ]
Hamidi-Sofiani, Vahideh [1 ]
Ebrahimian, Arefeh [1 ]
Shayestehpour, Mohammad [4 ,5 ]
机构：
[1] Golestan Univ Med Sci, Dept Microbiol, Gorgan, Golestan, Iran
[2] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
[3] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran
[4] Kashan Univ Med Sci, Fac Med, Autoimmune Dis Res Ctr, Kashan, Iran
[5] Kashan Univ Med Sci, Fac Med, Dept Microbiol & Immunol, POB 8715988141,5th Qotb E Ravandi Blvd, Kashan, Iran
来源：
REVIEWS AND RESEARCH IN MEDICAL MICROBIOLOGY | 2022年 / 33卷 / 02期
关键词：
Crimean-Congo hemorrhagic fever; hemorrhagic fever; vaccine; zoonotic; VESICULAR STOMATITIS-VIRUS; ENCEPHALITIS-VIRUS; IMMUNE-RESPONSE; GLYCOPROTEIN; PATHOGENESIS; INFECTION; EXOSOMES; ANKARA; LETHAL; MICE;
D O I：
10.1097/MRM.0000000000000260
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Crimean-Congo hemorrhagic fever (CCHF) has been recognized as a tick-borne infection caused by a member of the Nairoviridae family within the Bunyavirales order, named CCHF virus. CCHF virus is a zoonotic virus, so transferred between vertebrates and humans. Therefore, vaccination in humans and animals might reduce the risk of infection. Currently, there are no globally licensed vaccines or therapeutics for CCHF. Although several studies have been performed on the production of the CCHF vaccine, any of these vaccines were not fully protective. Hence, the development of a new generation of vaccines could contribute to better management of CCHF. In this review, we will discuss on features of these vaccine candidates. Copyright (C) 2021 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码：109 / 116
页数：8
相关论文
共 90 条
[1]   Pathogenesis of Crimean-Congo Hemorrhagic Fever [J].
Akinci, Esragul ;
Bodur, Hurrem ;
Leblebicioglu, Hakan .
VECTOR-BORNE AND ZOONOTIC DISEASES, 2013, 13 (07) :429-437
[2]   An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens [J].
Anticoli, Simona ;
Manfredi, Francesco ;
Chiozzini, Chiara ;
Arenaccio, Claudia ;
Olivetta, Eleonora ;
Ferrantelli, Flavia ;
Capocefalo, Antonio ;
Falcone, Emiliana ;
Ruggieri, Anna ;
Federico, Maurizio .
BIOTECHNOLOGY JOURNAL, 2018, 13 (04)
[3]   Exosomes in Therapy: Engineering, Pharmacokinetics and Future Applications [J].
Arenaccio, Claudia ;
Chiozzini, Chiara ;
Ferrantelli, Flavia ;
Leone, Patrizia ;
Olivetta, Eleonora ;
Federico, Maurizio .
CURRENT DRUG TARGETS, 2019, 20 (01) :87-95
[4]  
Arntzen CJ, 1997, PUBLIC HEALTH REP, V112, P190
[5]  
Atkinson B, 2012, EUROSURVEILLANCE, V17, P7
[6]   Exosomes: Therapy delivery tools and biomarkers of diseases [J].
Barile, Lucio ;
Vassalli, Giuseppe .
PHARMACOLOGY & THERAPEUTICS, 2017, 174 :63-78
[7]   The Non-structural Protein of Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane Potential and Induces Apoptosis [J].
Barnwal, Bhaskar ;
Karlberg, Helen ;
Mirazimi, Ali ;
Tan, Yee-Joo .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (02) :582-592
[8]   Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity [J].
Bente, Dennis A. ;
Forrester, Naomi L. ;
Watts, Douglas M. ;
McAuley, Alexander J. ;
Whitehouse, Chris A. ;
Bray, Mike .
ANTIVIRAL RESEARCH, 2013, 100 (01) :159-189
[9]   Pathogenesis and Immune Response of Crimean-Congo Hemorrhagic Fever Virus in a STAT-1 Knockout Mouse Model [J].
Bente, Dennis A. ;
Alimonti, Judie B. ;
Shieh, Wun-Ju ;
Camus, Gaelle ;
Stroeher, Ute ;
Zaki, Sherif ;
Jones, Steven M. .
JOURNAL OF VIROLOGY, 2010, 84 (21) :11089-11100
[10]   Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice [J].
Bereczky, Sandor ;
Lindegren, Gunnel ;
Karlberg, Helen ;
Akerstrom, Sara ;
Klingstrom, Jonas ;
Mirazimi, Ali .
JOURNAL OF GENERAL VIROLOGY, 2010, 91 :1473-1477
123456789